These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 9816045

  • 1. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG, Dobberstein KU, Fittkau M, Bahn H, Holzhausen HJ, Gantchev L, Burkert W.
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC.
    Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].
    Huober J, Sprenger H, Costa SD, Zentgraf H, Schmid H, Kaufmann M, Bastert G.
    Zentralbl Gynakol; 1996 Jan; 118(10):560-4. PubMed ID: 8999710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH, Bayona W, Koslow M, Newcomb EW.
    Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human gliomas with wild-type p53 express bcl-2.
    Alderson LM, Castleberg RL, Harsh GR, Louis DN, Henson JW.
    Cancer Res; 1995 Mar 01; 55(5):999-1001. PubMed ID: 7867012
    [Abstract] [Full Text] [Related]

  • 13. Correlation of p53 immunoreactivity and sequencing in patients with glioma.
    Kyritsis AP, Xu R, Bondy ML, Levin VA, Bruner JM.
    Mol Carcinog; 1996 Jan 01; 15(1):1-4. PubMed ID: 8561860
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP.
    Cancer Res; 1992 Aug 01; 52(15):4168-74. PubMed ID: 1322237
    [Abstract] [Full Text] [Related]

  • 17. Mutations of the p53 gene in gliomas from Malay patients.
    Jafri A, Aziz MY, Ros S, Nizam I.
    Med J Malaysia; 2003 Jun 01; 58(2):236-42. PubMed ID: 14569744
    [Abstract] [Full Text] [Related]

  • 18. Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.
    Lianidou ES, Levesque MA, Katsaros D, Angelopoulou K, Yu H, Genta F, Arisio R, Massobrio M, Bharaj B, Diamandis EP.
    Anticancer Res; 1999 Jun 01; 19(1B):749-56. PubMed ID: 10216487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.